β-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The nature of the progressive beta-cell failure occurring as normal glucose tolerant (NGT) individuals progress to type 2 diabetes (T2DM) is incompletely understood. We measured insulin sensitivity (by a euglycemic insulin clamp) and insulin secretion rate (by deconvolution of plasma C-peptide levels during an oral glucose tolerance test) in 188 subjects [19 lean NGT (body mass index [BMI] </= 25 kg/m(2)), 42 obese NGT, 22 BMI-matched impaired glucose tolerance [IGT], and 105 BMI-matched T2DM]. Main determinants of beta-cell function on the oral glucose tolerance test were derived from a mathematical model featuring the following: 1) glucose concentration-insulin secretion dose response (glucose sensitivity), 2) a secretion component proportional to the derivative of plasma glucose concentration (rate sensitivity); and 3) a potentiation factor. When NGT and T2DM were subgrouped by 2-h plasma glucose concentrations, insulin secretion rate revealed an inverted U-shaped pattern, rising through NGT up to IGT and falling off thereafter. In contrast, beta-cell glucose sensitivity dropped in a monophasic, curvilinear fashion throughout the range of 2-h plasma glucose. Within the NGT range (2-h glucose of 4.1-7.7 mmol/liter), beta-cell glucose sensitivity declined by 50-70% (P < 0.02). Insulin sensitivity decreased sharply in the transition from lean to obese NGT and then declined further in IGT and mild T2DM to level off in the higher three quartiles of diabetic hyperglycemia. In T2DM, defective beta-cell potentiation and rate sensitivity also emerged (P </= 0.05). In the whole data set, insulin sensitivity and the dynamic parameters of beta-cell function explained 89% of the variability of 2-h plasma glucose levels. The following conclusions were reached: 1) beta-cell glucose sensitivity falls already within the NGT range in association with rising 2-h plasma glucose concentrations, although absolute insulin secretion rates increase; and 2) throughout the glucose tolerance range, dynamic parameters of beta-cell function (glucose sensitivity, rate sensitivity, and potentiation) and insulin sensitivity are independent determinants of 2-h plasma glucose levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The slope of the relationship between glucose and insulin secretion (ie, β -CGS) is a major controller of postprandial glu cose levels (23, 24).”
From Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test (2024) · cites this paper as [24]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · cited 2×
“5] -cell glucose sensitivity (pmol min 1 m 2 mM (1)) 147 [97] 92 [98] 55 [34] 14 [15]”
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Martin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Nauck, M. A., Kleine, N., �rskov, C., Holst, J. J., Willms, B., & Creutzfeldt, W. (1993) · Diabetologia · doi:10.1007/bf00401145 · Cited by 1,092 · cited 1×
“Fasting plasma insulin (pmol/liter) 20 [16] 48 [32] 74 [47] 94 [58] Insulin AUC (nmol/liter h) 22 [15] 45 [38] 65 [33] 24 [23] I/ G (pmol/mmol) 73 [84] 163 [172] 122 [140] 19 [33] Fasting ISR (pmol/min m (2)) 53 [34] 85 [53] 116 [39] 112 [71] Total IS (nmol m (2)) 30 [18] 43 [19] 47 [17] 24 [19] Insulin sensitivity (M…”
Cited by
Items 401–500 of 538
Bariatric surgery normalizes diabetes risk index by one month post-operation
Sinatra, V. J., Lin, B., Parikh, M., Berger, J. S., Fisher, E. A. A., & Heffron, S. P. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-02002-x · Cited by 6
“Finally, oral glucose tolerance testing (OGTT) requires a 2-h monitoring period and studies have indicated that beta cell dysfunction evidenced by diminished insulin secretion is often present even within a range defining normal glucose tolerance (2-h plasma glucose of < 140 mg/dL) [19, 20].”
BackgroundLinkens, A. M. A., Eussen, S. J. P. M., Houben, A. J. H. M., Mari, A., Dagnelie, P. C., Stehouwer, C. D. A., & Schalkwijk, C. G. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.05.021 · Cited by 6
Self-citationDecreased islet sensitivity to insulin in hamsters with dietary-induced insulin resistance
Francini, F., Gagliardino, J. J., & Borelli, M. I. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.01.012 · Cited by 6
“People with type 2 diabetes or with impaired glucose tolerance have lower β-cell sensitivity to glucose (Ferrannini et al., 2005).”
Backgroundβ‐Cell mass and function in human type 2 diabetes
Marchetti, P., & Ferrannini, E. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch24 · Cited by 13
Self-citationNoncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes
Ramanadham, S., TURK, J. W., & Bhatnagar, S. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220031 · Cited by 13
“When the clinical diagnosis of T2D is made, the β -cell function is already reduced by 70% (4, 5, 60, 85).”
Rahman, M. M., Pathak, A., Schueler, K. L., Alsharif, H. A., Michl, A. N., Alexander, J., Kim, J., & Bhatnagar, S. (2023) · The FASEB Journal · doi:10.1096/fj.202300291rr · Cited by 5
Physiological Fatty Acid-Stimulated Insulin Secretion and Redox Signaling Versus Lipotoxicity
Ježek, P. (2025) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0799 · Cited by 9
Leahy, J. L., & Pratley, R. E. (2011) · Translational endocrinology & metabolism · doi:10.1210/team.9781879225824.ch1 · Cited by 9
Schianca, G. P. C., Fra, G. P., Bigliocca, M., Mella, R., Rossi, L. C., & Bartoli, E. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12185 · Cited by 5
Too Many Notes: Up and Down the Scales of Diabetes Therapy
Vinik, A. I. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.002 · Cited by 5
Li, Y., He, S.-H., Sun, Y., Li, G., Xu, Q., Wang, C., & Jia, W. (2017) · IUBMB Life · doi:10.1002/iub.1657 · Cited by 6
“Impaired bCGS was a characteristic sign of even minimally impaired glucose tolerance (IGT), and declined bCGS already existed within the normal glucose range (19,20).”
BackgroundPharmaceutical Interventions for Diabetes Prevention in Patients at Risk
Chatterjee, S., Davies, M. J., & Khunti, K. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0239-y · Cited by 5
Insulin resistance versus β-cell dysfunction in the pathogenesis of type 2 diabetes
Ferrannini, E. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0031-8 · Cited by 5
“Glucose sensitivity declines monotonically from normal glucose tolerance to diabetes through IGT [ 8 ], is essentially unrelated to insulin sensitivity, and is a strong predictor of incident diabetes in nondiabetic subjects [4].”
BackgroundSelf-citationType 2 diabetes: Prescription patterns and treatment outcomes of IDMPS survey in Argentina
José, G. J., Elgart, J. F., Forti, L., Querzoli, I., & CHANTELOT, J.-M. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.008 · Cited by 7
Early postprandial Insulin secretion: Its relation to Insulin sensitivity
Kabadi, U. M., & Kabadi, M. U. (2011) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2011.11001 · Cited by 5
Normal Fasting Plasma Glucose Levels and Type 2 Diabetes in Young Men
Leahy, J. L. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70279-8 · Cited by 5
Pharmacological Prevention of Type 2 Diabetes
Scheen, A. J. (2008) · Wiley eBooks · doi:10.1002/9780470779750.ch29 · Cited by 6
“Sulphonylureas/glinides While defective insulin secretion has been long considered as a latter event in the natural history of T2DM, recent studies have clearly demonstrated that there is an early defect in B-cell function [47], even in individuals with IGT [48], especially when insulin secretion is evaluated in compa…”
BackgroundRubino, M., Massimino, M., Mancuso, E., Averta, C., Palummo, A., Perticone, M., Succurro, E., Sciacqua, A., Mannino, G. C., & Andreozzi, F. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02576-2 · Cited by 9
STING and metabolism-related diseases: Roles, mechanisms, and applications
Zhang, Z., Wang, X., Zhao, C., Zhu, H., Liao, X., & Tsai, H. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111833 · Cited by 4
Yang, C., Chai, X., Wang, Y., Li, D., Zhu, D., Liang, K., Wang, J., Yang, Z., Gong, Q., Zhang, J., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02722-8 · Cited by 5
“In NGT-1hPG-high individuals, insulin resistance may result in a delayed insulin peak and prolonged postprandial hyperglycemia [40], which could potentially explain the association between 1-h PG and atherogenic lipid parameters.”
Xiong, G.-X., Xiong, L., & Li, X. (2016) · Laser Physics · doi:10.1088/1054-660x/26/9/095605 · Cited by 4
Reddy, N. V. L. S., & Akhila, M. (2015) · Cited by 4
Prediabetes: challenges and opportunities
Моргунова, Т. Б., Glinkina, I. V., & Fadeev, V. V. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-220-227 · Cited by 5
Mendham, A. E., Micklesfield, L. K., Karpe, F., Kengne, A. P., Chikowore, T., Kufe, C. N., Masemola, M., Crowther, N. J., Norris, S. A., Olsson, T., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05788-1 · Cited by 4
“The prevalence of IFG 185 Diabetologia (2023) 66:174–189 and IGT vary between ethnic groups, with a low prevalence of IFG alongside a high rate of IGT and type 2 diabetes in Black South African cohorts studied previously [63] and in the current cohort.”
BackgroundInfluentialBala, C. G., Rusu, A., Moise, M., & Román, G. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0020 · Cited by 4
“One of the main barriers in maintaining long-term glycemic control in T2D is the progressive nature of the disease attributed to a continuous decline in beta-cell function [9] and many patients require insulin after a number of years since diagnosis [10].”
BackgroundReview: The importance of effective early phase insulin secretion
Prato, S. D., Miccoli, R., & Penno, G. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050040401 · Cited by 4
Natali, A., Prato, S. D., & Mari, A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch8 · Cited by 5
Self-citationDiabetes Drugs: Present and Emerging
Tilley, J., Grimsby, J. S., Erickson, S. D., & Berthel, S. J. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc198 · Cited by 4
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Prato, S. D., Bianchi, C., & Daniele, G. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch12 · Cited by 15
Othman, N. A., Docherty, P. D., & Chase, J. G. (2014) · IFAC Proceedings Volumes · doi:10.3182/20140824-6-za-1003.02097 · Cited by 3
“Understanding the UN secretion profile is thus a critical aspect of characterizing this metabolic disorder (Ferrannini et al., 2005, Pacini et al., 2003).”
BackgroundRemote ischemic conditioning: A potential therapeutic strategy of type 2 diabetes
Liu, J., Sun, X., Jin, H., Yan, X., Huang, S., Guo, Z., & Yang, Y. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110409 · Cited by 4
Kevin, C., & Tia, M. (2011) · InTech eBooks · doi:10.5772/21963 · Cited by 3
DISTq: Low-Cost, Accurate and Real-Time Estimation of Insulin Sensitivity
Docherty, P. D., Chase, J. G., Lotz, T., Hann, C. E., Shaw, G. M., Berkeley, J. E., Mann, J. I., & McAuley, K. A. (2009) · IFAC Proceedings Volumes · doi:10.3182/20090812-3-dk-2006.00016 · Cited by 4
Assessment of beta cell function in subjects with newly diagnosed type 2 diabetes
Cernea, S., Huţanu, A., Coroş, L., & Dobreanu, M. (2013) · Revista română de medicină de laborator · doi:10.2478/rrlm-2013-0011 · Cited by 3
Suzuki, T., Takahashi, K., Fujiwara, D., Shii, M., Takekawa, S., & Matsuoka, T. (2015) · Diabetology International · doi:10.1007/s13340-015-0239-6 · Cited by 4
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M. A., Peters, A. L., Τσάπας, Α., Wender, R. C., & Matthews, D. R. (2012) · Cited by 3
Self-citationOthman, N. A., Docherty, P. D., Krebs, J. D., Bell, D. A., & Chase, J. G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817750402 · Cited by 3
Carotid Bodies: Use of Chemosensitivity as a Biomarker in Prediabetes
Conde, S. V., Lages, M., Guarino, M. P., & Sacramento, J. F. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_38 · Cited by 3
Model-Based Therapeutics for Type 1 Diabetes Mellitus
Wong, X. (2008) · UC Research Repository (University of Canterbury) · doi:10.26021/1222 · Cited by 8
Critical Evaluation of Models to Identify Individuals With Insulin Resistance
Rathmann, W., Haastert, B., Giani, G., Holle, R., Köenig, W., Herder, C., & Löwel, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1833 · Cited by 3
Analysis and Optimisation of Model-Based Insulin Sensitivity and Secretion Tests
Othman, N. A. (2015) · UC Research Repository (University of Canterbury) · doi:10.26021/2367 · Cited by 6
Salmon, J. A., Magbuhat, A. L., Guerrero-Sali, R. J., Purino, F., Macindo, J. R. B., & MERCADO-ASIS, L. B. (2024) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.039.02.19 · Cited by 2
Evans‐Molina, C., Gitelman, S. E., Mari, A., & Ferrannini, E. (2026) · Diabetologia · doi:10.1007/s00125-026-06703-8 · Cited by 2
“The beta cell function model employed was originally developed and applied in cohorts of individuals with normal or impaired glucose tolerance and type 2 diabetes [31–33].”
Self-citationInsulin/IGF signaling in islet biology and its therapeutic implications
Kim, H., & Kulkarni, R. N. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag014 · Cited by 2
Tracking the progression to type 2 diabetes with a proportional-derivative insulin secretion model
Othman, N. A., Docherty, P. D., Damanhuri, N. S., & Chase, J. G. (2016) · Control Engineering Practice · doi:10.1016/j.conengprac.2016.10.012 · Cited by 3
Assessment of Islet Alpha- and Beta-Cell Function
Madsbad, S., & Holst, J. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_2 · Cited by 4
β-Cell Heterogeneity and Plasticity
Yong, H. J., & Wang, Y. J. (2024) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-031-62232-8_3 · Cited by 2
Masrouri, S., Zadeh, S. S. T., Tohidi, M., Azizi, F., & Hadaegh, F. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14308 · Cited by 4
Tura, A., Göbl, C. S., El‐Tanani, M., & Rizzo, M. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2024.1452400 · Cited by 3
“Indeed, Ferrannini et al. (21) found that GSENS declined in monophasic curvilinear fashion throughout the range of the 2-h plasma glucose.”
L’hyperglycémie provoquée par voie orale (HGPO) revisitée
Scheen, A. J., & Luyckx, F. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70163-2 · Cited by 3
DREAM — a diabetes prevention study
Conlon, D. (2006) · The British Journal of Diabetes · doi:10.1177/14746514060060050501 · Cited by 2
L’hyperglycémie provoquée par voie orale (HGPO) revisitée
Scheen, A. J., & Luyckx, F. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70124-3 · Cited by 6
Glycemic Index and Diabetes Mellitus
(2016) · CRC Press eBooks · doi:10.1201/9781315371764-5 · Cited by 2
(SFD), U. P. D. P. P. P. L. S. F. D. D. (2012) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(12)70660-0 · Cited by 2
Mitrea, A., Vladu, I. M., Rosu, M. M., Clenciu, D., Moța, E., & Moța, M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002510 · Cited by 2
Combination therapy in type 2 diabetes mellitus
Abdul‐Ghani, M. A., DeFronzo, R. A., & Eldor, R. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch46 · Cited by 3
Self-citationKim, S. K., Kim, J. H., Park, J. Y., No, H. S., Jang, K., Heo, J. S., Choi, S. H., Choi, D. W., & Kim, K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.04.020 · Cited by 2
Valdez, C. A. (2008) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2008.14.7.650 · Cited by 2
Jamaludin, U. K. (2013) · UMP Institutional Repository (Universiti Malaysia Pahang) · doi:10.26021/3488 · Cited by 3
“2001) and weight loss (Camastra et al. 2005; Ferrannini et al. 2005; Ferrannini et al. 1997) are proven to improve sensitivity and thus reduce the prevalence or impact of type 2 diabetes.”
BackgroundMatcha Tea and its Acute Effects on Postprandial Blood Glucose
Romash, R. G. (2018) · Arizona State University Library Digital Repository (Arizona State University) · Cited by 2
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Prato, S. D., Bianchi, C., & Daniele, G. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch16 · Cited by 5
Hoyeck, M. P., Ching, M. E. A., Palaniyandi, J., Fadzeyeva, E., Kolic, J., Ashley‐Martin, J., Lyon, J., Smith, N., Mulvihill, E. E., Johnson, J. D., et al. (2025) · medRxiv · doi:10.1101/2025.04.26.25326263 · Cited by 2
Glycemic response of honey and dates consumption
Ali, D., Mohammedsalih, R. R., & Salih, R. M. (2022) · Baghdad Journal of Biochemistry and Applied Biological Sciences · doi:10.47419/bjbabs.v3i01.83 · Cited by 2
Current Insights into Laboratory Markers for Diagnosing Metabolic Syndrome
Ayrapetyan, S. A., & Shishkin, A. N. (2025) · Juvenis scientia · doi:10.32415/jscientia_2025_11_2_5-20 · Cited by 1
Cuthbertson, D. J., Whyte, M., Henney, A. E., Alam, U., Goff, L. M., Fielding, B. A., & Umpleby, A. M. (2026) · Obesity Reviews · doi:10.1111/obr.70104 · Cited by 3
Aiello, E., Grieco, G. E., Brunetti, M., Gliozzo, G., Fignani, D., Quero, G., Alfieri, S., Giuseppe, G. D., Ciccarelli, G., Dardano, A., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06766-7 · Cited by 1
“…retrieve unique indices of beta cell function, including GS and RS. RS quantifies early-phase insulin release and provides a direct measure of beta cell function that mirrors the characteristic reduction in first-phase insulin secretion typically seen in individuals with type 2 diabetes [34, 35].”
Self-citationDocherty, P. D., & Chase, J. G. (2013) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2012.12.002 · Cited by 1
New ways to test beta cell functionality in health and diabetes
Korsgaard, T. V. (2011) · Cited by 1
Incretins: new targets for the prevention of diabetes and obesity
Neff, K., & le Roux, C. W. (2013) · Clinical Lipidology · doi:10.2217/clp.12.80 · Cited by 1
OS EFEITOS DA SUPLEMENTAÇÃO DE ÁCIDO FÓLICO NA NEUROPATIA DIABÉTICA
Nakahara, K. R., Pagnussat, J. V., Fernandes, L. S., Shimabukuro, S. N., & Pescador, M. V. B. (2019) · FAG JOURNAL OF HEALTH (FJH) · doi:10.35984/fjh.v1i3.142
Khan, M. U., & Udaya, M. (2011) · InTech eBooks · doi:10.5772/24413 · Cited by 2
Carotid Bodies:Use of Chemosensitivity as a Biomarker in Prediabetes
Conde, S. V., Lages, M., Guarino, M. P., & Sacramento, J. F. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_38-1 · Cited by 4
Fuelling Life and Managing Surplus: Revisiting Type 2 Diabetes
Gudat, U. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002613 · Cited by 1
Palmer, A. K., & Kirkland, J. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00012-8 · Cited by 2
Sweet Spot Regulation of Maternal Metabolic Health and Nutrition on β-Cell Mass in the Offspring
Chung, G., Wong, A., Her, T. K., & Alejandro, E. U. (2024) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-031-62232-8_7 · Cited by 1
Trends in mean serum insulin and hyperinsulinemia among US adults without diabetes 1999–2018
Johnson, T. M., & Churilla, J. R. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109159 · Cited by 1
Кушнарёва, Н. Н., Zinych, О. В., Ковальчук, А., Прибила, О., & Шишкань-Шишова, Е. А. (2021) · World Science · doi:10.31435/rsglobal_ws/30032021/7507 · Cited by 1
Metabolic Syndrome, Diabetes and Nonalcoholic Steatohepatitis
Kyrou, I., Haukeland, J. W., Bhala, N. B., & Kumar, S. (2009) · Wiley eBooks · doi:10.1002/9781444307627.ch16 · Cited by 2
Kim, C. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.3.154 · Cited by 1
“Other studies demonstrated that the decline in β-cell function occurs at an earlier stage that is considered normal according to current diagnostic criteria [8,10,11].”
BackgroundNovel Roles of p21 in Apoptosis During Beta-Cell Stress in Diabetes
Hernandez, A. M. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2008 · Cited by 1
Ning, F. (2013) · Helda - University of Helsinki Institutional Repository
Pham, R. N., & Do, T. M. N. (2011) · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver
Félix‐Martínez, G. J., Leehan, J. A., Ávila-Pozos, R., & Fernández, J. R. G. (2014) · Revista Mexicana de Ingeniería Biomédica · Cited by 2
Fransson, L. (2014) · Figshare
Serine/Threonine Protein Phosphatase 5 - a Double-edged Sword - in the Progression towards Diabetes
Grankvist, N. (2012) · Figshare
Diabetes mellitus in Adults - Aspects of Incidence, Autoimmunity and C-peptide
Thunander, M. (2011) · Lund University Publications (Lund University)
β-Cell Dysfunction and the Onset of Type 2 Diabetes
Fennoy, I. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.01.050
Albai, O., & Timar, R. Z. (2012) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/v10255-012-0004-6
PMMJS Study Group, Zhou, H., Yang, C., Guo, Z., Hu, X., Xu, Y., & Zhou, Z. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0332-1
“However, other studies suggested that the traditional risk factors, such as the combination of family history, high blood sugar, insulin resistance, and inflammatory markers, could predict T2DM more efficiently than MS or its components [26].”
BackgroundKrentz, A. J., Heinemann, L., & Hompesch, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4920-0_2
“Insulin secretion rates rise through the range between normal glucose tolerance to IGT and decline thereafter [ 75 ].”
BackgroundThe effects of the adipocyte-secreted proteins resistin and visfatin on the pancreatic beta-cell
Onyango, D. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Buchanan, T. A. (2007)
Cernea, S., Hu, A., Coroş, L., & Dobreanu, M. (2013)
Diabetes in China 3 Early therapy for type 2 diabetes in China
Yang, W., & Key, G. P. (2014)
Stress-inducible Mig6 promotes pancreatic beta cell destruction in the pathogenesis of diabetes
Chen, Y. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2003
Mechanisms of transcriptional regulation in the maintenance of β cell function
Maganti, A. V. (2015) · IUScholarWorks (Indiana University) · doi:10.7912/c2b88b
“1 Introduction Deficiency of insulin secretion underlies the transition from normoglycemia to hyperglycemia in both type 1 and type 2 diabetes (225,226).”
BackgroundOn Glucose Metabolism in Patients with the m.3243A>G Mutation
Lindroos, M. M. (2013) · UTUPub (University of Turku)
Robust Modelling of the Glucose-Insulin System for Tight Glycemic Control of Critical Care Patients
Lin, J. (2007) · UC Research Repository (University of Canterbury) · doi:10.26021/1585 · Cited by 4
Metadata
- Authors
- Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A.
- Affiliations
- University of Pisa (IT)
- The University of Texas at San Antonio Health Science Center (US)
- National Research Council (IT)
- Corresponding author
- Ferrannini, Ele
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-01
- Volume
- 90
- Issue
- 1
- Pages
- 493-500
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1981581852
- Semantic Scholar
- 1e59c003bc095926431f049735ca1064ebb24a32
- Cited by
- 540
- References
- 45
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 20 · 2023: 20 · 2022: 27 · 2021: 19 · 2020: 21 · 2019: 22 · 2018: 25 · 2017: 26 · 2016: 21 · 2015: 33 · 2014: 33 · 2013: 26 · 2012: 32
- FWCI
- 29.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 24092)
- National Center for Research Resources (M01RR01346, M01RR001346)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- beta-cell function, type 2 diabetes, impaired glucose tolerance, insulin sensitivity, insulin secretion rate, beta-cell glucose sensitivity, rate dependence, C-peptide, hyperinsulinemic-euglycemic clamp, oral glucose tolerance test, obesity, 2-hour plasma glucose
- MeSH terms
- Insulin Secretion, Adult, Blood Glucose, Cross-Sectional Studies, Diabetes Mellitus, Fatty Acids, Nonesterified, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.